Zobrazeno 1 - 3
of 3
pro vyhledávání: '"José Carlos Méndez Méndez"'
Autor:
Ana Fernández Montes, Alberto Carmona-Bayonas, Paula Jimenez-Fonseca, Francisca Vázquez Rivera, Nieves Martinez Lago, Marta Covela Rúa, Antía Cousillas Castiñeiras, Paula Gonzalez Villarroel, Juan De la Cámara Gómez, José Carlos Méndez Méndez, Carmen Carriles Fernández, Manuel Sanchez Cánovas, Teresa Garcia García
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Trifluridine/tipiracil increases overall survival (OS) in patients with refractory, metastatic colorectal cancer (mCRC). A post hoc exploratory analysis of the RECOURSE randomized clinical trial (RCT) established two categories, a good progn
Externí odkaz:
https://doaj.org/article/79955248229f4b8ab9ff4d86bc53b994
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PLoS ONE, Vol 17, Iss 6 (2022)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://doaj.org/article/e00901a0b5b7464ca871c78422a4ada3
Autor:
Nieves Martínez-Lago, Soledad Cameselle García, Beatriz Alonso de Castro, Martín I. Gómez-Randulfe Rodríguez, Marta Carmona Campos, Paula González Villarroel, Mercedes Salgado Fernández, Juan C. De la Cámara Gómez, Carlos Romero Reinoso, Antía Cousillas Castiñeiras, José Carlos Méndez Méndez, Yolanda Vidal Insua, Ana Fernández-Montes
Publikováno v:
PloS one. 17(6)
Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ≥65 years. Thus, we seek to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeaaf1c74f10bfe501df8239567e0e09
https://pubmed.ncbi.nlm.nih.gov/35657983
https://pubmed.ncbi.nlm.nih.gov/35657983